Literature DB >> 16400691

Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.

John M Luk1, Chi-Tat Lam, Annie F M Siu, Brian Y Lam, Irene O L Ng, Mei-Yu Hu, Chi-Ming Che, Sheung-Tat Fan.   

Abstract

To facilitate the identification of candidate molecular biomarkers that are linked to the pathogenesis of hepatocellular carcinoma (HCC), we investigated protein-expression profiles of 146 tissue specimens including 67 pairs of tumors and adjacent non-tumors resected from HCC patients as well as 12 normal livers by 2-DE. Among the 1800 spots displayed in the liver proteome, a total of 90 protein species were found to be significantly different between the three groups (P < 0.05). Three of the top candidate markers up-regulated in HCC, with high receiver operating characteristic (ROC) curves, were identified by MS/MS analysis and belonged to the chaperone members: heat-shock protein (Hsp)27, Hsp70 and glucose-regulated protein (GRP)78. Over-expression of these chaperone proteins in HCC tissues was confirmed by Western blotting and immunohistochemistry. In correlation with clinico-pathological parameters, expression of Hsp27 was linked to alpha-fetoprotein level (P = 0.007) whereas up-regulation of GRP78 was associated with tumor venous infiltration (P = 0.035). No significant association of Hsp70 with any pathologic features was observed. The present HCC proteome analysis revealed that in response to the stressful cancerous microenvironment, tumor cells strived to increase the expression of chaperone proteins for cyto-protective function and to enhance tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400691     DOI: 10.1002/pmic.200500306

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  58 in total

1.  Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma.

Authors:  Fu Yang; Ling Zhang; Fang Wang; Yue Wang; Xi-song Huo; Yi-xuan Yin; Yu-qi Wang; Lin Zhang; Shu-han Sun
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

2.  Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.

Authors:  W-J Lu; N P Lee; S C Kaul; F Lan; R T P Poon; R Wadhwa; J M Luk
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

3.  NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.

Authors:  Vignesh Ramesh; Karthikeyan Selvarasu; Jaishree Pandian; Soundarajan Myilsamy; Chidambaranathan Shanmugasundaram; Kumaresan Ganesan
Journal:  Cell Oncol (Dordr)       Date:  2016-08-25       Impact factor: 6.730

4.  Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

Authors:  Lei Chen; David W Y Ho; Nikki P Y Lee; Stella Sun; Brian Lam; Kwong-Fai Wong; Xin Yi; George K Lau; Eddy W Y Ng; Terence C W Poon; Paul B S Lai; Zongwei Cai; Jirun Peng; Xisheng Leng; Ronnie T P Poon; John M Luk
Journal:  Ann Surg Oncol       Date:  2010-03-31       Impact factor: 5.344

5.  Serum heat shock protein 27 levels in patients with hepatocellular carcinoma.

Authors:  Gabriella Gruden; Patrizia Carucci; Valentina Lolli; Loretta Cosso; Erika Dellavalle; Emanuela Rolle; Alessandro Cantamessa; Silvia Pinach; Maria Lorena Abate; Donata Campra; Franco Brunello; Graziella Bruno; Mario Rizzetto; Paolo Cavallo Perin
Journal:  Cell Stress Chaperones       Date:  2012-10-17       Impact factor: 3.667

6.  GRP78 and GAL3, differentially regulated by lymph node homogenates, as potential biomarkers for lymph node metastasis in mouse hepatocellular carcinoma cells.

Authors:  Wenjun Zhu; Lawrence Owusu; Shizhu Zang; Yunjuan Zhang; Yi Xin; Chao Yan
Journal:  Oncol Lett       Date:  2012-09-13       Impact factor: 2.967

7.  Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest and apoptosis.

Authors:  Go Watanabe; Kevin E Behrns; Jae-Sung Kim; Robin D Kim
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-12       Impact factor: 3.333

8.  A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States.

Authors:  Jesus M Matos; Frank A Witzmann; O William Cummings; C Max Schmidt
Journal:  J Surg Res       Date:  2008-07-16       Impact factor: 2.192

9.  Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.

Authors:  Weijie Liu; Yanlei Ma; Long Huang; Jiayuan Peng; Peng Zhang; Huizhen Zhang; Jie Chen; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2009-10-16       Impact factor: 2.316

10.  A protein-based set of reference markers for liver tissues and hepatocellular carcinoma.

Authors:  Stella Sun; Xin Yi; Ronnie Tp Poon; Chun Yeung; Philip J R Day; John M Luk
Journal:  BMC Cancer       Date:  2009-09-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.